Are synonymous codons indeed synonymous?

Biomolecular Concepts

Volumn 3, Issue 1, 2012, Pages 21-28

  Venetianer, Pál ^a  

^a INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

Author keywords

isoaccepting tRNA; miRNA; mRNA half life; mRNA secondary structure; synonymous codon; translation kinetics

Indexed keywords

EID: 84875254678     PISSN: 18685021     EISSN: 1868503X     Source Type: Journal    
DOI: 10.1515/bmc.2011.050     Document Type: Review

References (54)

1. Schattner P, Diekhans M. Regions of extreme synonymous codon selection in mammalian genes. Nucl Acids Res 2006; 34: 1700-10.
2. Chamary JV, Parmley JL, Hurst LD. Hearing silence: non-neutral evolution at synonymous sites in mammals. Nature Revs Genet 2006; 7: 98-108.
3. Parmley JL, Urrutia AO, Potrzebowski L, Kaessmann H, Hurst LD. Splicing and the evolution of proteins in mammals. PLoS Biol 2007; 5: e14. doi: 10.1371/journal.pbio.0050014.
4. Parmley JL, Hurst LD. How do synonymous mutations affect fitness? BioEssays 2007; 29: 515-9.
5. Plotkin JB, Kudla G. Synonymous but not the same: the causes and consequences of codon bias. Nature Revs Genet 2011; 12: 32-42.
6. Ikemura T. Correlation between the abundance of Escherichia coli transfer RNAs and the occurence of the respective codons in its protein genes. J Mol Biol 1981; 146: 1-21.
7. Lavner Y, Kotlar D. Codon bias as a factor in regulating expression via translation rate in the human genome. Gene 2005; 345: 127-38.
8. Comeron JM. Selective and mutational patterns associated with gene expression in humans: influences on synonymous composition and intron presence. Genetics 2004; 167: 1293-304.
9. Czech A, Fedyunin I, Zhang G, Ignatova Z. Silent mutations in sight: co-variations in tRNA abundance as a key to unravel consequences of silent mutations. Mol Biosyst 2010; 10: 1767-72.
10. Angov E, Hillier CJ, Kincaid RL, Lyon JA. Heterologous protein expression is enhanced by harmonizing the codon usage frequencies of the target gene with those of the expression host. PLoS One 2008; 3(5): e2189. doi: 10.1371/journal.pone.0002189.
11. Coleman JR, Papamichail D, Skiena S, Futcher B, Wimmer E, Mueller S. Virus attenuation by genome-scale changes in codon pair bias. Science 2008; 320: 1784-7.
12. Sharp PM, Li WH. The Codon Adaptation Index-a measure of directional synonymous codon usage bias, and its potential applications. Nucl Acids Res 1987; 15: 1281-95.
13. Pagani F, Raponi M, Baralle FE. Synonymous mutations in CFTR exon 12 affect splicing and are not neutral in evolution. Proc Natl Acad Sci USA 2005; 102: 6368-72.
14. Cartegni L, Chew SL, Krainer AR. Listening to silence and understanding nonsense: exonic mutations that affect splicing. Nature Revs Genet 2002; 3: 285-98.
15. Amati-Bonneau P, Pasquier L, Lainey E, Ferre M, Odent S, Malthiery Y, Bonneau D, Reynier P. Sporadic optic atrophy due to synonymous codon change altering mRNA splicing of OPA1. Clin Genet 2005; 67: 102-3.
16. Fernandez-Cadenas I, Andreu AL, Gamez J, Gonzalo R, Martin MA, Rubio JC, Arenas J. Splicing mosaic of the myophosphorylase gene due to a silent mutation in McArdle disease. Neurology 2003; 61: 1432-4.
17. Du YZ, Dickerson C, Aylsworth AS, Schwartz CE. A silent mutation, C924T (G308G), in the L1CAM gene results in X linked hydrocephalus (HSAS). J Med Genet 1998; 35: 456-62.
18. Xie JL, Pabon D, Jayo A, Butta N, Gonzalez-Manchon C. Type I Glanzmann thrombasthenia caused by an apparently silent β 3 mutation that results in aberrant splicing and reduced β 3 mRNA. Thromb Haemost 2005; 67: 897-903.
19. Flusser H, Korman SH, Sato K, Matsubara Y, Galil A, Kure S. Mild glycine encephalopathy (NKH) in a large kindred due to a silent exonic GLDC splice mutation. Neurology 2005; 64: 1426-30.
20. Wicklow BA, Ivanovich JL, Plews MM, Salo TJ, Noetzel MJ, Lueder GT, Cartegni L, Kaback MM, Sandhoff K, Steiner RD, Triggs-Raine BL. Severe subacute GM2 gangliosidosis caused by an apparently silent HEXA mutation (V324V) that results in aberrant splicing and reduced HEXA mRNA. Am J Med Genet A 2004; 127A: 158-66.
21. Liu W, Quian C, Francke U. Silent mutation induces exon skipping of fibrilin-1 gene in Marfan syndrome. Nat Genet 1997; 16: 328-9.
22. Chao HK, Hsiao KJ, Su TS. A silent mutation induces exon skipping in the phenylalanine hydroxylase gene in phenylketonuria. Hum Genet 2001; 108: 14-9.
23. Caceres JF, Komblihtt AR. Alternative splicing: multiple control mechanisms and involvement in human disease. Trends Genet 2002; 18: 186-93.
24. Chamary JV, Hurst LD. Biased codon usage near intron-exon junctions: selection on splicing enhancers, splice-site recognition or something else? Trends Genet 2005; 21: 256-9.
25. Kudla G, Murray AW, Tollervey D, Plotkin JB. Coding-sequence determinants of gene expression in Escherichia coli. Science 2009; 324: 255-8.
26. Welch M, Govindarajan S, Nees JE, Villalobos A, Gurney A, Minshull J, Gustafsson C. Design parameters to control synthetic gene expression in Escherichia coli. PLoS One 2009; 4: e7002. doi: 10.1371/journal.pone.0007002.
27. De Smit MH, van Duin J. Secondary structure of the ribosomal binding site determines translational efficiency: a quantitative analysis. Proc Natl Acad Sci USA 1990; 87: 7668-72.
28. Goltermann L, Borch Jensen M, Bentin T. Tuning protein expression using synonymous codon libraries targeted to the 5mRNA coding region. Protein Eng Des Sel 2011; 24: 123-9.
29. Nackley AG, Shabalina SA, Tchivileva IE, Satterfield K, Korchynskyi O, Makarov SS, Maixner W, Diatchenko L. Human catechol-O-methyltransferase haplotypes modulate protein expression by altering mRNA secondary structure. Science 2006; 314: 1930-3.
30. Tsao D, Shabalina SA, Gauthier J, Dokholyan NV, Diatchenko L. Disruptive mRNA folding increases translational efficiency of catechol-O-methyltransferase variant. Nucleic Acids Res 2011; 39: 6201-12.
31. Bartoszewski RA, Jablonsky M, Bartoszewska S, Stevenson L, Dai Q, Kappes J, Collawn JF, Bebok Z. A synonymous nucleotide polymorphism in A F508 CFTR alters the secondary structure of the mRNA and the expression of the mutant protein. J Biol Chem 2010; 285: 28741-8.
32. Duan J, Wainwright MS, Comeron JM, Saitou N, Sanders AR, Gelernter J, Gejman PV. Synonymous mutations in the human dopamine receptor D2 (DRD2) affect mRNA stability and synthesis of the receptor. Human Mol Genet 2003; 12: 205-16.
33. Duan J, Antezana MA. Mammalian mutation pressure, synonymous codon choice and mRNA degradation. J Mol Evol 2003; 57: 694-701.
34. Chamary JV, Hurst LD. Evidence for selection on synonymous mutations affecting stability of mRNA secondary structure in mammals. Genome Biol 2005; 6: R75. doi: 10.1186/gb-2005-6-9-r75.
35. Capon F, Allen MH, Ameen M, Burden AD, Tillman D, Barker JN, Trembath RC. A synonymous SNP of the corneodesmin gene leads to increased mRNA stability and demonstrates association with psoriasis across diverse ethnic groups. Human Mol Genet 2004; 13: 2361-8.
36. Hurst LD. Preliminary assessment of the impact of microRNAmediated regulation on coding sequence evolution in mammals. J Mol Evol 2006; 63: 174-82.
37. Brest P, Lapaquette P, Souidi M, Lebrigand K, Cesaro A, Vouret-Craviari V, Mari B, Barbry P, Mosnier J-F, Hebuterne X, Harel-Bellan A, Mograbi B, Darfeuille-Michaud A, Hofman P. A synonymous variant in IRGM alters a binding site for miR-196 and causes deregulation of IRGM-dependent xenophagy in Crohn s disease. Nat Genet 2011; 43: 242-6.
38. Parkes M, Barrett JC, Prescott NJ, Tremeling M, Anderson CA, Fisher SA, Roberts RG, Nimmo ER, Cummings FR, Soars D, Drummond H, Lees CW, Khawaja SA, Bagnall R, Burke DA, Todhunter CE, Ahmad T, Onnie CM, McArdle W, Strachan D, Bethel G, Bryan C, Lewis CM, Deloukas P, Forbes A, Sanderson J, Jewell DP, Satsangi J, Mansfield JC, the Wellcome Trust Case Control Consortium, Cardon L, Mathew CG. Sequence variants in the autophagy gene IRGM and multiple other replicating loci contribute to Crohn s disease susceptibility. Nat Genet 2007; 39: 830-2.
39. Thanaraj TA, Argos P. Protein secondary structural types are differentially coded on messger RNA. Protein Sci 1996; 5: 1973-83.
40. Oresic M, Shalloway D. Specific correlations between relative synonymous codon usage and protein secondary structural units. J Mol Biol 1998; 281: 31-48.
41. Komar AA. A pause for thought along the co-translational folding pathway. Trends Biochem Sci 2008; 34: 16-24.
42. Zhang G, Hubalewska M, Ignatova Z. Transient ribosomal attenuation coordinates protein synthesis and co-translational folding. Nature Struct Mol Biol 2009; 16: 274-80.
43. Deane CM, Saunders R. The imprint of codons on protein structure. Biotechnol J 2011; 6: 641-9.
44. Angov E. Codon usage: nature s roadmap to expression and folding of proteins. Biotechnol J 2011; 6: 650-9.
45. Cortazzo P, Cervenansky C, Marin M, Reiss C, Ehrlich R, Deana A. Silent mutations affect in vivo protein folding in Escherichia coli. Biochem Biophys Res Comm 2002; 293: 537-41.
46. Kimchi-Sarfaty C, Oh JM, Kim IW, Sauna ZE, Calcagno AM, Ambudkar SV, Gottesman MM. A silent polymorphism in the MDR1 gene changes substrate specificity. Science 2007; 315: 525-8.
47. Wang D, Johnson AD, Papp AC, Kroetz DL, Sad e e W. Multidrug resistance polypeptide 1 (MDR1, ABCB1) variant 3435C δ T affects mRNA stability. Pharmacogen Genom 2005; 15: 693-704.
48. Fung KL, Gottesman MM. A synonymous polymorphism in a common MDR1 (ABCB1) haplotype shapes protein function. Biochim Biophys Acta 2009; 1794: 860-71.
49. Sauna ZE, Kimchi-Sarfaty C, Ambudkar SV, Gottesman MM. Silent polymorphisms speak: how they affect pharmacogenomics and the treatment of cancer. Cancer Res 2007; 67: 9609-12.
50. Hunt R, Sauna ZE, Ambudkar SV, Gottesman MM, Kimchi-Sarfaty C. Silent (synonymous) SNPs: should we care about them? Methods Mol Biol 2009; 578: 23-39.
51. Zhang F, Saha S, Shabalina SA, Kashina A. Differential arginylation of actin isoforms is regulated by coding sequence-dependent degradation. Science 2010; 329: 1534-7.
52. Yang R, Chen B, Hemminki K, Wappenschmidt B, Engel C, Sutter C, Ditsch N, Weber BH, Niederacher D, Arnold N, Meindl A, Bartram CR, Schmutzler RK, Burwinkel B. Polymorphisms in BRCA2 resulting in aberrant codon-usage and their analysis on familial breast cancer risk. Breast Cancer Res Treat 2009; 118: 407-13.
53. Li M, Wang, IX, Li Y, Bruzel A, Richards AL, Toung JM, Cheung VG. Widespread RNA and DNA sequence differences in the human transcriptome. Science 2011; 333: 53-8.
54. Yanagitani K, Kimata Y, Kadokura H, Kohno K. Translational pausing ensures membrane targeting and cytoplasmic splicing of XBP1u mRNA. Science 2011; 331: 586-9.